{"Exaggerate": "The claim exaggerates the increase in price from $100 to over $600 for Epipens.", "Falters at times": "The claim falters in accurately representing the impact of the ballot initiative on the price of Epipens.", "Lack enough support": "The claim lacks sufficient evidence to support the assertion that the ballot initiative will lower the price tag for Epipens.", "Problematic assumption": "The claim assumes that the high price of Epipens is solely due to the lack of choice and knowledge by consumers.", "Exist alternative explanation": "The claim fails to acknowledge the existence of alternative, lower-priced generic options for Epipens."}